David Chen
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
-
- Renal cell carcinoma treatment
- Advanced Breast Cancer Therapies
- Lung Cancer Treatments and Mutations
Papers in
-
- Renal cell carcinoma treatment 14
- Lung Cancer Treatments and Mutations 4
- Prostate Cancer Diagnosis and Treatment 3
- Surgery 10
- Bladder and Urothelial Cancer Treatments 3
- Co-authors
- Sarat Chandarlapaty (2 shared papers)José Baselga (2 shared papers)Michael F. Berger (1 shared paper)Rita A. Sakr (1 shared paper)Sean William Fanning (1 shared paper)Clifford A. Hudis (1 shared paper)Marie Will (1 shared paper)Zhiqiang Li (1 shared paper)
- Journals
- The Journal of Urology (8 papers)Journal of Clinical Oncology (5 papers)European Urology (2 papers)American Journal of Health-System Pharmacy (2 papers)The American Surgeon (2 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
David Chen
54 papers receiving 4.1k citations
David Chen's Hit Papers
Peers
Comparison fields: 5 of 123
- Cancer Research 809
- Pulmonary and Respiratory Medicine 1.5k
- Oncology 1.1k
- Physiology 652
- Genetics 576
Countries citing papers authored by David Chen
This map shows the geographic impact of David Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Chen more than expected).
Fields of papers citing papers by David Chen
This network shows the impact of papers produced by David Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Chen. The network helps show where David Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside David Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ESR1 ligand-binding domain mutations in hormone-resistant breast cancer Hit paper breakdown → | 2013 | 1014 |
| 2 | Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2013 | 708 |
| 3 | Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer Hit paper breakdown → | 2016 | 411 |
| 4 | 2016 | 214 | |
| 5 | 2012 | 198 | |
| 6 | 2016 | 181 | |
| 7 | 2020 | 159 | |
| 8 | 2021 | 127 | |
| 9 | 2011 | 119 | |
| 10 | 2006 | 117 | |
| 11 | 2018 | 110 | |
| 12 | 2016 | 80 | |
| 13 | 1970 | 73 | |
| 14 | 2015 | 70 | |
| 15 | 2020 | 60 | |
| 16 | 2007 | 57 | |
| 17 | 2016 | 39 | |
| 18 | 2016 | 39 | |
| 19 | 2000 | 37 | |
| 20 | 2019 | 37 |
About David Chen
David Chen is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Molecular Biology and Geriatrics and Gerontology, having authored 55 papers that have together received 4.2k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (14 papers), Renal and related cancers (5 papers), Tuberous Sclerosis Complex Research (4 papers), Lung Cancer Treatments and Mutations (4 papers), Prostate Cancer Diagnosis and Treatment (3 papers), Neuroendocrine Tumor Research Advances (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (809 citations), Pulmonary and Respiratory Medicine (1.5k citations), Oncology (1.1k citations), Physiology (652 citations) and Genetics (576 citations). David Chen has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Sarat Chandarlapaty, José Baselga, Michael F. Berger, Rita A. Sakr, Sean William Fanning, Clifford A. Hudis, Marie Will, Zhiqiang Li, Helen H. Won and Maurizio Voi. Their work appears in journals such as The Journal of Urology, Journal of Clinical Oncology, European Urology, American Journal of Health-System Pharmacy and The American Surgeon.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.